M Volm
Impact in
- Oncology top 0.5%
- Drug Transport and Resistance Mechanisms
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
-
- Cancer therapeutics and mechanisms 39
- Angiogenesis and VEGF in Cancer 17
- Glutathione Transferases and Polymorphisms 17
- RNA modifications and cancer 17
- Oncology 119
- Drug Transport and Resistance Mechanisms 57
- Co-authors
- Reet Koomägi (49 shared papers)J Mattern (106 shared papers)Thomas Efferth (49 shared papers)Jürgen Mattern (35 shared papers)K. Wayss (57 shared papers)G. Stammler (29 shared papers)Axel Sauerbrey (23 shared papers)P. Drings (9 shared papers)
- Journals
- International Journal of Oncology (15 papers)British Journal of Cancer (14 papers)Die Naturwissenschaften (11 papers)International Journal of Cancer (10 papers)Journal of Cancer Research and Clinical Oncology (10 papers)
- Partner nations
- GermanyHungaryUnited States
In The Last Decade
M Volm
273 papers receiving 6.5k citations
Peers
Comparison fields: 5 of 128
- Oncology 2.8k
- Cancer Research 1.4k
- Molecular Biology 3.3k
- Pulmonary and Respiratory Medicine 1.0k
- Pharmacology 272
Countries citing papers authored by M Volm
This map shows the geographic impact of M Volm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Volm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Volm more than expected).
Fields of papers citing papers by M Volm
This network shows the impact of papers produced by M Volm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Volm. The network helps show where M Volm may publish in the future.
Co-authors
The 25 scholars most cited alongside M Volm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 289 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 389 | |
| 2 | 1996 | 279 | |
| 3 | 1997 | 198 | |
| 4 | Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. | 2000 | 177 |
| 5 | 1998 | 160 | |
| 6 | 2008 | 153 | |
| 7 | Multidrug resistance and its reversal. | 1998 | 138 |
| 8 | 2009 | 136 | |
| 9 | 2011 | 128 | |
| 10 | Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma. | 1988 | 123 |
| 11 | 2005 | 122 | |
| 12 | 1998 | 121 | |
| 13 | 1989 | 116 | |
| 14 | 1979 | 100 | |
| 15 | 1999 | 94 | |
| 16 | 1985 | 92 | |
| 17 | 1985 | 91 | |
| 18 | Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma. | 1985 | 89 |
| 19 | 1997 | 88 | |
| 20 | 2015 | 87 |
About M Volm
M Volm is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 289 papers that have together received 6.9k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (57 papers), Lung Cancer Treatments and Mutations (47 papers), Cancer therapeutics and mechanisms (39 papers), Angiogenesis and VEGF in Cancer (17 papers), Acute Lymphoblastic Leukemia research (17 papers), Glutathione Transferases and Polymorphisms (17 papers), RNA modifications and cancer (17 papers) and Cancer, Hypoxia, and Metabolism (16 papers). The work is most often cited by research in Oncology (2.8k citations), Cancer Research (1.4k citations), Molecular Biology (3.3k citations), Pulmonary and Respiratory Medicine (1.0k citations) and Pharmacology (272 citations). M Volm has collaborated with scholars based in Germany, Hungary and United States. Frequent co-authors include Reet Koomägi, J Mattern, Thomas Efferth, Jürgen Mattern, K. Wayss, G. Stammler, Axel Sauerbrey, P. Drings, F Zintl and Werner Rittgen. Their work appears in journals such as International Journal of Oncology, British Journal of Cancer, Die Naturwissenschaften, International Journal of Cancer and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.